Abstract: The invention provides compositions for inhibiting a redox-sensitive GTPase protein, including a Rho or Rab family GTPase, comprising an effective amount of a redox-sensitive purine compound and an effective amount of a redox agent. The invention further provides methods of inhibiting a redox-sensitive GTPase protein, including a Rho or Rab family GTPase, by administering compositions of the invention. Methods of screening for compounds that inhibit a redox-sensitive GTPase protein, including compounds that target and inhibit Rho or Rab family GTPases, are further provided.
Type:
Grant
Filed:
December 21, 2011
Date of Patent:
May 20, 2014
Assignee:
Board of Regents, The University of Texas System
Abstract: The present invention relates to a monoclonal antibody or fragment thereof, which binds specifically to the cyclin-dependent kinase 5 (Cdk5) activating protein, p25 and not to p35, a hybridoma cell line producing the monoclonal antibody, and methods for the detection and/or isolation of p25, p25 fragments or homologs thereof from biological material. The invention further relates to the use of the monoclonal antibody or fragment thereof for detection and treatment of neuronal disorders and cancers.
Type:
Grant
Filed:
June 3, 2010
Date of Patent:
May 20, 2014
Assignee:
The Board of Regents of the University of Texas System
Abstract: Systems and methods provide a high-level language for generation of a scheduling specification based on a scheduling policy, and synthesis of scheduler based on the scheduling specification. The systems and methods can permit the use of more sophisticated scheduling strategies than those afforded by conventional systems, without requiring the programmer to write explicitly parallel code. In certain embodiments, synthesis of the scheduler includes implementation of at least one rule related to the scheduling specification through definition of one or more workset objects that are concurrent, a workset object of the one or more workset objects having an addition method, a first poll method, and a second poll method. Such poll methods extend the operability of sequential poll methods. The one or more worksets satisfy a condition for correctness that is less stringent than conventional conditions for correctness.
Type:
Grant
Filed:
June 6, 2011
Date of Patent:
May 20, 2014
Assignee:
Board Of Regents Of the University of Texas System
Abstract: The present invention includes a hydrogel and a method of making a porous hydrogel by preparing an aqueous mixture of an uncrosslinked polymer and a crystallizable molecule; casting the mixture into a vessel; allowing the cast mixture to dry to form an amorphous hydrogel film; seeding the cast mixture with a seed crystal of the crystallizable molecule; growing the crystallizable molecule into a crystal structure within the uncrosslinked polymer; crosslinking the polymer around the crystal structure under conditions in which the crystal structure within the crosslinked polymer is maintained; and dissolving the crystals within the crosslinked polymer to form the porous hydrogel.
Type:
Grant
Filed:
June 4, 2013
Date of Patent:
May 20, 2014
Assignee:
Board of Regents, The University of Texas System
Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
Type:
Grant
Filed:
December 4, 2009
Date of Patent:
May 20, 2014
Assignee:
The Board of Regents, The University of Texas System
Inventors:
William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
Abstract: The present invention includes an apparatus and method for removing oil from a oil-containing liquid comprising oil and gas comprising: a source of oil-containing liquid; and a membrane contactor system in fluid communication with the source of oil-containing liquid, the membrane contactor system comprising one or more membrane contactors having a first and a second surface, wherein the first surface coalesces oil and removes gas from the oil-containing liquid, and the oil and gas are collected on the second surface from the oil-containing liquid.
Type:
Application
Filed:
December 9, 2013
Publication date:
May 15, 2014
Applicants:
Organic Fuels Algae Technologies, LLC, Board of Regents, The University of Texas System
Inventors:
Frank Seibert, Stephen William Briggs, Stacy S. Truscott, Peter B. Kipp
Abstract: A system, method and apparatus assesses a risk of one or more assets within an operational technology infrastructure by providing a database containing data relating to the one or more assets, calculating a threat score for the one or more assets using one or more processors communicably coupled to the database, calculating a vulnerability score for the one or more assets using the one or more processors, calculating an impact score for the one or more assets using the one or more processors, and determining the risk of the one or more assets based on the threat score, the vulnerability score and the impact score using the one or more processors.
Type:
Application
Filed:
November 12, 2013
Publication date:
May 15, 2014
Applicant:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Inventors:
Salvador Cordero, Eduardo Obregon, Irbis Gallegos
Abstract: Methods and compositions are used to identify and characterize new channelrhodopsins derived from algae and several of which are red-shifted. The rhodopsin domain of these red-shifted channelrhodopsins can be cloned and expressed in mammalian systems and used in optogenetic applications and as therapeutic agents. Also provided are methods and compositions for use in red-shifting the absorbance maxima of channelrhodopsins in order to improve their utility for use in vivo.
Type:
Application
Filed:
October 14, 2013
Publication date:
May 15, 2014
Applicant:
Board of Regents of the University of Texas System
Inventors:
John Lee SPUDICH, Elena G. GOVORUNOVA, Oleg A. SINESHCHEKOV
Abstract: An autophagy-inducing compound comprises an autophagy-inducing peptide comprising beclin-1 residues 269-283 and a heterologous moiety that promotes therapeutic stability or delivery of the compound. The compound may be used to induce autophagy and in assays with beclin-1 binding partners.
Type:
Grant
Filed:
November 8, 2013
Date of Patent:
May 13, 2014
Assignee:
Board of Regents, The University of Texas System
Inventors:
Beth C. Levine, Sanae Shoji-Kawata, Olivier Lichtarge, Angela D. Wilkins
Abstract: The present invention relates to DNA sequences encoding Vmp-like polypeptides of pathogenic Borrelia, the use of the DNA sequences in recombinant vectors to express polypeptides, the encoded amino acid sequences, application of the DNA and amino acid sequences to the production of polypeptides as antigens for immunoprophylaxis, immunotherapy, and immunodiagnosis. Also disclosed are the use of the nucleic acid sequences as probes or primers for the detection of organisms causing Lyme disease, relapsing fever, or related disorders, and kits designed to facilitate methods of using the described polypeptides, DNA segments and antibodies.
Type:
Grant
Filed:
October 5, 2012
Date of Patent:
May 13, 2014
Assignee:
Board of Regents, The University of Texas Systems
Abstract: The present invention includes compositions and methods of making cation-substituted and fluorine-substituted spinel cathode compositions by firing a LiMn2?y?zLiyMzO4 oxide with NH4HF2 at low temperatures of between about 300 and 700° C. for 2 to 8 hours and a ? of more than 0 and less than about 0.50, mixed two-phase compositions consisting of a spinel cathode and a layered oxide cathode, and coupling them with unmodified or surface modified graphite anodes in lithium ion cells.
Type:
Grant
Filed:
April 1, 2010
Date of Patent:
May 13, 2014
Assignee:
Board of Regents of the University of Texas System
Abstract: The present invention relates to compounds and methods for inducing synthesis and secretion of insulin from pancreatic beta cells. The methods may take place in vitro, ex vivo such as in isolates from adult mammalian tissue, or in vivo. Compounds and methods described herein may find use in the treatment of diabetes.
Type:
Grant
Filed:
November 21, 2012
Date of Patent:
May 13, 2014
Assignee:
The Board of Regents of the University of Texas System
Abstract: Methods of diagnosing and prognosticating the development of human cancers, such as breast cancer, colon cancer, and pancreatic cancer, are provided. The diagnostic and prognostic methods include the detection and/or quantifying of the amount of expression of JAB1 in human cells, particularly in relation to the amount of p27 or c-Jun. In addition, methods for reducing the expression of JAB1 protein in cells and inhibiting its interaction with p27 or c-Jun, for example, are provided.
Type:
Grant
Filed:
October 18, 2007
Date of Patent:
May 13, 2014
Assignee:
Board of Regents, The University of Texas System
Abstract: A method for treating and/or diagnosing pain and the source or type of pain, shock, and/or inflammatory conditions in a subject. A method of using a therapeutically effective amount of a DNA or RNA aptamer that shows high affinity for OLAMs to at least partially treat pain, shock, and/or inflammatory conditions in a subject. The DNA or RNA aptamer that shows high affinity for OLAMs may be coupled to a plasma protein binding compound or a pharmacologically active agent. A method of treating and or diagnosing pain, shock, and/or inflammatory conditions in a subject may include inactivating or preventing at least one linoleic acid metabolite to treat certain conditions (e.g., pain, shock, and/or inflammation) using a DNA or RNA aptamer that shows high affinity for OLAMs.
Type:
Application
Filed:
September 17, 2013
Publication date:
May 8, 2014
Applicant:
Board of Regents of the University of Texas System
Inventors:
Kenneth Michael Hargreaves, John Gordon Bruno
Abstract: Methods and composition for denoising digital camera images are provided herein. The method is based on directly measuring the local statistical structure of natural images in a large training set that has been corrupted with noise mimicking digital camera noise. The measured statistics are conditional means of the ground truth pixel value given a local context of input pixels. Each conditional mean is the Bayes optimal (minimum mean squared error) estimate given the specific local context. The conditional means are measured and applied recursively (e.g., the second conditional mean is measured after denoising with the first conditional mean). Each local context vector consists of only three variables, and hence the conditional means can be measured directly without prior assumptions about the underlying probability distributions, and they can be stored in fixed lookup tables.
Type:
Application
Filed:
August 12, 2013
Publication date:
May 8, 2014
Applicant:
Board of Regents, the University of Texas System
Abstract: The present invention includes compound compositions and methods of making compounds that include an oligo-benzamide compound having at least two optionally substituted benzamides.
Type:
Application
Filed:
October 28, 2013
Publication date:
May 8, 2014
Applicant:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Abstract: The present invention relates to the selective modulation of pre-mRNA splicing, in particular, for that involving alternative splicing in disease-related proteins such as those involved in Duschenne's Muscular Dystropy and Spinal Muscular Atrophy.
Type:
Application
Filed:
March 23, 2012
Publication date:
May 8, 2014
Applicant:
The Board of Regents of the University of Texas System
Abstract: The present invention provides a method of regulating fatty acid metabolism in a cell by contacting the cell with a modulator of miR-378 and/or miR-378* activity or expression. The present invention also provides a method of treating or preventing a metabolic disorder, such as obesity, diabetes, or metabolic syndrome, in a subject by administering to the subject an inhibitor of miR-378 and/or miR-378* expression or activity. Methods of treating or preventing pathologic cardiac hypertrophy, cardiac remodeling, myocardial infarction, or heart failure in a subject by inhibiting the expression or activity of miR-378 and/or miR-378* in a subject are also disclosed.
Type:
Grant
Filed:
June 6, 2011
Date of Patent:
May 6, 2014
Assignee:
The Board of Regents, The University of Texas System
Abstract: A magnetic coupling for connecting a cannula to the apex of a ventricle comprising a first member having a first orifice, a first magnetic material attached to the first member, a means for attaching a cannula to the first member, a second member having a second orifice, a second magnetic material attached to the second member, a means for attaching the second member to a ventricle, so that when the first magnet is placed in proximity to the second magnet the first member and second member are held substantially concentric by magnetic force to allow for the communication of fluid between the first and second orifices.
Type:
Grant
Filed:
September 1, 2011
Date of Patent:
May 6, 2014
Assignee:
The Board of Regents of the University of Texas Systems
Inventors:
Thomas D. Pate, Jeffrey R Gohean, Raul G. Longoria, Richard W. Smalling